Cherokee Nation v. McKesson Corp. (In re Nat'l Prescription Opiate Litig.)

327 F. Supp. 3d 1064
CourtDistrict Court, N.D. Ohio
DecidedSeptember 4, 2018
DocketMDL No. 2804; Case No. 17-md-2804
StatusPublished
Cited by8 cases

This text of 327 F. Supp. 3d 1064 (Cherokee Nation v. McKesson Corp. (In re Nat'l Prescription Opiate Litig.)) is published on Counsel Stack Legal Research, covering District Court, N.D. Ohio primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Cherokee Nation v. McKesson Corp. (In re Nat'l Prescription Opiate Litig.), 327 F. Supp. 3d 1064 (N.D. Ohio 2018).

Opinion

Dan Aaron Polster, United States District Judge

Before the Court are Plaintiffs' Cherokee Nation ("Cherokee") and Lac Courte Oreilles Band of Lake Superior Chippewa Indians ("Lac Courte Oreilles") (collectively "the Tribes") Motions to Remand. (1:18-OP-45695 Doc # : 12; 1:18-OP-45932 Doc # : 15) The Court has reviewed the Motions, the Opposition Briefs, and the Reply Briefs of both cases and for the reasons to follow, DENIES both the Cherokee and the Lac Courte Oreilles Motions to Remand.

Additionally, for the reasons set forth below, Defendant McKesson Corporation's *1068("McKesson") Motion to Stay Execution of Any Remand Order pending in Case no. 1:18-OP-45695 (Doc # : 72) and Cherokee's Motion for Oral Argument pending in the same case (1:18-OP-45695 Doc # : 73) are also DENIED .

I. Introduction

In this Multidistrict Litigation ("MDL"), Plaintiffs are government entities, Indian tribes, hospitals, third-party payors and individuals from across the nation that have sued the manufacturers, distributors and retailers of prescription opiate drugs, alleging they are liable for the costs Plaintiffs have incurred, and will continue to incur, in addressing the opioid public health crisis. There are now over 1150 cases in the MDL-53 of which were filed by Indian tribes.

A. Procedural History re: Cherokee Nation v. McKesson Corporation et al. , Case No. 1:18-OP-45695

On April 20, 2017, Cherokee filed a petition in the District Court of the Cherokee Nation against defendant opioid distributors and pharmacies. (See 1:18-OP-45695 Doc # : 12 at 3) The defendants, in turn, filed a declaratory judgment action in the District Court for the Northern District of Oklahoma on June 8, 2017 seeking to enjoin the tribal lawsuit. (See Id. ) The Federal District Court granted defendants' motion for preliminary injunction on January 9, 2018. (See Id. )

Ten days later, on January 19, 2018, Cherokee filed this action in the District Court of Sequoyah County, Oklahoma. (1:18-OP-45695 Doc # : 2-1) Cherokee asserted solely state common law claims related to alleged actions and omissions of McKesson Corporation et al. that allowed opioid diversion to occur in the counties of Cherokee Nation in northeastern Oklahoma. On February 26, 2018 Defendant McKesson removed the case to the United States District Court for the Eastern District of Oklahoma alleging as its grounds for removal the Federal Officer Removal Statute, 28 U.S.C. § 1442. (1:18-OP-45695 Doc # : 2 at 2) McKesson subsequently filed a Notice of Potential Tag-Along Action relating to the present National Prescription Opiate MDL whereon the case was transferred to the Northern District of Ohio. (See 1:18-OP-45695 Doc # : 12 at 4; see also Doc # : 69)

B. Procedural History re: Lac Courte Oreilles Band Of Lake Superior Chippewa Indians v. McKesson Corporation et al , Case No. 1:18-OP-45932

Similarly, on March 16, 2018, Lac Courte Oreilles filed a Complaint in the Circuit Court of Sawyer County, Wisconsin against defendant opioid manufacturers, distributors, and pharmacies. (1:18-OP-45932 Doc # : 1-1 at 26-95) Lac Courte Oreilles similarly asserted only state law claims. On April 19, 2018 McKesson removed the case to the United States District Court for the Western District of Wisconsin-again alleging as its grounds for removal the Federal Officer Removal Statute. (1:18-OP-45932 Doc # : 1 at 3) Here, Defendant Cardinal Health, Inc. filed a Notice of Potential Tag-Along Action relating to the present National Prescription Opiate MDL whereon the case was transferred to the Northern District of Ohio. (See 1:18-OP-45932 Doc # : 15 at 4; see also Doc # : 27)

II. Standard of Review

When a case is removed under the Federal Officer Removal Statute, the Court is free to use its own circuit's interpretation of the federal law to form its opinion. See In re Korean Air Lines Disaster of September 1, 1983 , 829 F.2d 1171, 1186 (D.C. Cir. 1987) ("Nothing in the Supreme Court's opinion in Van Dusen *1069nor in the language of section 1407(a) requires a federal court to engage in the unprecedented practice of interpreting federal law through the analytical prism of another circuit's case law.").Therefore, in deciding the present motions, the Court will apply Sixth Circuit case law to its analysis of the Federal Officer Removal Statute.

Title 28, Section 1442 of the U.S. Code permits the removal of a "civil action or criminal prosecution that is commenced in a State court and that is against or directed to ... any officer (or any person acting under that officer) of the United States ... in an official or individual capacity, for or relating to any act under color of such office." 28 U.S.C. § 1442.1 The Supreme Court has "made clear that the [Federal Officer Removal] Statute must be 'liberally construed.' Watson v. Philip Morris Companies, Inc. , 551 U.S. 142, 147, 127 S.Ct. 2301, 168 L.Ed.2d 42 (2007) (quoting Colorado v. Symes , 286 U.S. 510, 517, 52 S.Ct. 635, 76 L.Ed. 1253 (1932) ; also citing Arizona v. Manypenny , 451 U.S. 232, 242, 101 S.Ct. 1657, 68 L.Ed.2d 58 (1981) and Willingham v. Morgan ,

Related

Cite This Page — Counsel Stack

Bluebook (online)
327 F. Supp. 3d 1064, Counsel Stack Legal Research, https://law.counselstack.com/opinion/cherokee-nation-v-mckesson-corp-in-re-natl-prescription-opiate-litig-ohnd-2018.